当前位置: 首页 >> 检索结果
共有 6983 条符合本次的查询结果, 用时 2.5089352 秒

261. Corrigendum to: Chen H, Deng ZX, Sun J, et al. Chest. 2023;163(1):100-114.

来源: Chest. 2025年167卷5期1514-1515页

262. Corrigendum to: Moores LK, Tritschler T, Brosnahan S, et al. Chest. 2022;162(1):213-225.

来源: Chest. 2025年167卷5期1514页

263. APCCMPD and CHEST Medical Educator Scholar Fellowship: A Novel Mechanism to Build Diverse Medical Educators.

作者: Mary Elizabeth Kreider.;Kristin M Burkart.;Joyce Reitzner.;James A Frank.;Jack Buckley.;Doreen Addrizzo-Harris.
来源: Chest. 2025年167卷5期1285-1286页

264. Disease Beyond the Lungs: Optimal Care of Multi-Organ Disease After Lung Transplantation.

作者: A Whitney Brown.;Erin E Tallarico.;Virginia Steen.
来源: Chest. 2025年167卷5期1282-1284页

265. Rebuttal From Drs Oldham and Cottin.

作者: Justin M Oldham.;Vincent Cottin.
来源: Chest. 2025年167卷5期1279-1281页

266. Rebuttal From Drs Marinescu and Ryerson.

作者: Daniel-Costin Marinescu.;Christopher J Ryerson.
来源: Chest. 2025年167卷5期1278-1279页

267. COUNTERPOINT: Should the Progressive Pulmonary Fibrosis Clinical Practice Guideline Be Adopted for Clinical Practice? No.

作者: Justin M Oldham.;Vincent Cottin.
来源: Chest. 2025年167卷5期1274-1278页

268. POINT: Should the Progressive Pulmonary Fibrosis Clinical Practice Guideline Be Adopted for Clinical Practice? Yes.

作者: Daniel-Costin Marinescu.;Christopher J Ryerson.
来源: Chest. 2025年167卷5期1271-1273页

269. Homebound: Neighborhood Deprivation and Lung Nodule Follow-Up.

作者: Lawrence N Benjamin.;Christopher G Slatore.
来源: Chest. 2025年167卷5期1268-1270页

270. Epicardial Adipose Tissue and Pulmonary Arterial Hypertension.

作者: Farbod N Rahaghi.
来源: Chest. 2025年167卷5期1265-1267页

271. Increasing Sarcoidosis Mortality Rates in United States Veterans: Who Are More Affected and Why?

作者: Marios Rossides.
来源: Chest. 2025年167卷5期1263-1264页

272. Noninvasive BP Measurements, Regardless of Position, Are Not a Substitute for Intraarterial BP Monitoring in the Hemodynamically Unstable.

作者: Andrew Alberter.;Daniel J Haase.
来源: Chest. 2025年167卷5期1261-1262页

273. Do Not Resuscitate the Direct Laryngoscope.

作者: Michael F Aziz.
来源: Chest. 2025年167卷5期1259-1260页

274. Is a "Fine Tuning" of the Flow Rate During High Flow Oxygen Therapy Clinically Relevant?: The Optimal Setting of High Flow Nasal Cannula Should Be Explored Further.

作者: Alessandro Galazzi.;Giacomo Grasselli.
来源: Chest. 2025年167卷5期1257-1258页

275. History and Progress: New Indices for Assessing Progression From Contingency to Crisis Care Conditions.

作者: Kelly M Griffin.
来源: Chest. 2025年167卷5期1255-1256页

276. Frailty: A Target For Prevention?

作者: Peter Hanlon.
来源: Chest. 2025年167卷5期1253-1254页

277. Practice Patterns and Patient Travel Distances for Lung Cancer Surgery in the United States: Analyses of the Veterans Health Administration and the National Cancer Database.

作者: Steven Tohmasi.;Daniel B Eaton.;Nikki E Rossetti.;Brendan T Heiden.;Theodore S Thomas.;Martin W Schoen.;Ana A Baumann.;Su-Hsin Chang.;Yan Yan.;Mayank R Patel.;Whitney S Brandt.;Bryan F Meyers.;Benjamin D Kozower.;Varun Puri.
来源: Chest. 2025年168卷4期1067-1071页

278. Lung Cancer Screening Adherence in Centralized vs Decentralized Screening Programs: A Meta-Analysis of US Cohort Studies Among Individuals With Negative Baseline Results.

作者: Elochukwu Ezenwankwo.;Camden Jones.;Duong Thuy Nguyen.;Jan M Eberth.
来源: Chest. 2025年168卷3期797-809页
With rising interest in centralized lung cancer screening (LCS), synthesizing evidence to estimate its impact on annual adherence is critical for aligning practice with guideline recommendations.

279. Defining Interstitial Lung Disease Education in Pulmonary Fellowship: A Mixed Methods Study.

作者: Samantha Irene King.;Anna Neumeier.;Bridget Graney.;Maryl Kreider.;Ryan Peterson.;Tristan Huie.
来源: Chest. 2025年168卷4期967-979页
Patients with interstitial lung disease (ILD) often receive care from general pulmonologists because geographic and financial barriers limit access to specialized care centers. However, many graduating pulmonary fellows lack confidence in managing patients with ILD. Refining ILD education in pulmonary fellowship could address this gap, but what trainees must learn is not defined currently.

280. Trends in Medicare Spending on Drugs for Pulmonary Arterial Hypertension, 2012-2022.

作者: Jenny A Shih.;Charlie Lee.;William B Feldman.
来源: Chest. 2025年168卷4期1018-1022页
共有 6983 条符合本次的查询结果, 用时 2.5089352 秒